Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 0: clinchem.2005.062414v1, 2006; 10.1373/clinchem.2005.062414
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2005.062414v1
52/5/860    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Janssen, A. J.M.
Right arrow Articles by Rodenburg, R. J.T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Janssen, A. J.M.
Right arrow Articles by Rodenburg, R. J.T.

Received on October 20, 2005
Accepted on February 22, 2006

Endocrinology and Metabolism

Measurement of the Energy-Generating Capacity of Human Muscle Mitochondria: Diagnostic Procedure and Application to Human Pathology

Antoon J.M. Janssen 1, Frans J.M. Trijbels 1, Rob C.A. Sengers 1, Liesbeth T.M. Wintjes 1, Wim Ruitenbeek 1, Jan A.M. Smeitink 1, Eva Morava 1, Baziel G.M. van Engelen 2, Lambert P. van den Heuvel 1, Richard J.T. Rodenburg 1*

1 Department of Pediatrics and Laboratory of Pediatrics and Neurology, the Nijmegen Centre for Mitochondrial Disorders (NCMD), Nijmegen, The Netherlands
2 Department of Neurology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

* To whom correspondence should be addressed. E-mail: R.Rodenburg{at}cukz.umcn.nl.

Background: Diagnosis of mitochondrial disorders usually requires a muscle biopsy to examine mitochondrial function. We describe our diagnostic procedure and results for 29 patients with mitochondrial disorders.

Methods: Muscle biopsies were from 43 healthy individuals and 29 patients with defects in one of the oxidative phosphorylation (OXPHOS) complexes, the pyruvate dehydrogenase complex (PDHc), or the adenine nucleotide translocator (ANT). Homogenized muscle samples were used to determine the oxidation rates of radiolabeled pyruvate, malate, and succinate in the absence or presence of various acetyl Co-A donors and acceptors, as well as specific inhibitors of tricarboxylic acid cycle or OXPHOS enzymes. We determined the rate of ATP production from oxidation of pyruvate.

Results: Each defect in the energy-generating system produced a specific combination of substrate oxidation impairments. PDHc deficiencies decreased substrate oxidation reactions containing pyruvate. Defects in complexes I, III, and IV decreased oxidation of pyruvate plus malate, with normal to mildly diminished oxidation of pyruvate plus carnitine. In complex V defects, pyruvate oxidation improved by addition of carbonyl cyanide 3-chlorophenyl hydrazone, whereas other oxidation rates were decreased. In most patients, ATP production was decreased.

Conclusion: The proposed method can be successfully applied to the diagnosis of defects in PDHc, OXPHOS complexes, and ANT.


The following articles in journals at HighWire Press have cited this article:


Home page
 BMJ Case ReportsHome page
A. I Jonckheere, M. Hogeveen, L. Nijtmans, M. van den Brand, A. Janssen, H. Diepstra, F. van den Brandt, B. van den Heuvel, F. Hol, T. Hofste, et al.
A novel mitochondrial ATP8 gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathy
BMJ Case Reports, January 22, 2009; 2009(jan21_1): bcr0720080504 - bcr0720080504.
[Abstract] [Full Text]

Home page
 BrainHome page
S. B. Wortmann, R. J. T. Rodenburg, A. Jonckheere, M. C. de Vries, M. Huizing, K. Heldt, L. P. van den Heuvel, U. Wendel, L. A. Kluijtmans, U. F. Engelke, et al.
Biochemical and genetic analysis of 3-methylglutaconic aciduria type IV: a diagnostic strategy
Brain, January 1, 2009; 132(1): 136 - 146.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
A I Jonckheere, M Hogeveen, L G J Nijtmans, M A M van den Brand, A J M Janssen, J H S Diepstra, F C A van den Brandt, L P van den Heuvel, F A Hol, T G J Hofste, et al.
A novel mitochondrial ATP8 gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathy
J. Med. Genet., March 1, 2008; 45(3): 129 - 133.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. J.M. Janssen, F. J.M. Trijbels, R. C.A. Sengers, J. A.M. Smeitink, L. P. van den Heuvel, L. T.M. Wintjes, B. J.M. Stoltenborg-Hogenkamp, and R. J.T. Rodenburg
Spectrophotometric Assay for Complex I of the Respiratory Chain in Tissue Samples and Cultured Fibroblasts
Clin. Chem., April 1, 2007; 53(4): 729 - 734.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
R. Carrozzo, C. Dionisi-Vici, U. Steuerwald, S. Lucioli, F. Deodato, S. Di Giandomenico, E. Bertini, B. Franke, L. A. J. Kluijtmans, M. C. Meschini, et al.
SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness
Brain, March 1, 2007; 130(3): 862 - 874.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
E. Morava, L. van den Heuvel, F. Hol, M. C. de Vries, M. Hogeveen, R. J. Rodenburg, and J.A.M. Smeitink
Mitochondrial disease criteria: Diagnostic applications in children
Neurology, November 28, 2006; 67(10): 1823 - 1826.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the American Association for Clinical Chemistry.